Static Chart Revive Therapeutics Ltd.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 11:12:54 22/05/2024 pm IST			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	-16.67%

23/04	FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID	MT
23/04	Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID	MT

Duration

Period